• 대한핵의학회지
• /
• 제16권2호
• /
• pp.85-89
• /
• 1982

Patients with diffusely increased uptake in both kindeys("hot kidney") on the $^{99m}Tc-MDP$ bone imagings were evaluated. Total incidence of the "hot kidney" was 2.7% (56/2053). Among 56 patients with "hot kidney", the most common diseases were malignancies (30), and the remainders were composed of renal diseases(11) and other disease group(16). We report the possible factors for the "hot kidney" with brief review of some literatures.

• 대한핵의학회지
• /
• 제32권2호
• /
• pp.168-171
• /
• 1998

We present a case in which a patient with acute hemorrhagic gastritis demonstrated abnormal gastrointestinal accumulation of radiotracer during $^{99m}Tc$-methylene diphosphonate(MDP) skeletal scintigraphy. A hemorrhagic gastritis was subsequently demonstrated by endoscopy. The mechanism for the intestinal localization of $^{99m}Tc$-MDP in this patient is not clear, but we guess that the extravasated blood containing the radiopharmaceutical cannot recirculate and stays at the bleeding site, so we can see the intestinal activity.

• 대한핵의학회:학술대회논문집
• /
• 대한핵의학회 1986년도 제25차 춘계학술대회
• /
• pp.124.2-124.2
• /
• 1986

• 대한핵의학회지
• /
• 제16권2호
• /
• pp.81-84
• /
• 1982

To evaluate the in-vivo and in-vitro stability of methylene diphosphonate $(MDP)-^{99m}Tc$, relative ligand exchange rates in phosphate buffer between $MDP-^{99m}Tc$ and human serum albumin (HSA), and between pyrophosphate$(PYP)-^{99m}Tc$ and HSA have been measured. Gel permeation chromatography has also been carried out to estimate relative rates of ligand exchange between polysaccharide and the $^{99m}Tc-bone$ agents. The in-vitro stability was further correlated with its specific radioactivity. The results indicated that the $MDP-^{99m}Tc$ is more stable than the $PYP-^{99m}Tc$ but less stable than $MIDA-^{99m}Tc$, $HIDA-^{99m}Tc$, and $DTPA-^{99m}Tc$ etc. in refering to other data. In stability point of view, $MDP-^{99m}Tc$ is considered to be a better bone agent than $PYP-^{99m}Tc$ since $MDP-^{99m}Tc$ can be accumulated at bone by a smooth transfer of $^{99m}Tc$ to hydroxyapatite, whereas in case of $PYP-^{99m}Tc$, most of the $^{99m}Tc$ is transferred to HSA before arriving to the hydroxyapatite.

• Journal of Radiation Protection and Research
• /
• 제28권2호
• /
• pp.117-125
• /
• 2003

$^{99m}Tc$ 표지 방사성의약품을 이용한 핵의학 영상검사를 받은 환자들에서 방사선 적응반응이 개인간에 어느 정도 차이가 있는지 알아보고자 하였다. $^{99m}Tc-DTPA$ 신장 신티그라피를 시행한 환자 23명, $^{99m}Tc-MDP$ 골 신티그라피를 시행한 환자 18명 및 $^{99}mTc-TF$ 심근관류 신티그라피를 시행한 환자 21명, 총 62명의 환자를 대상으로 방사성의약품 주사 전, 그리고 주사후 4시간째 채혈하여 림프구를 채취 배양하였다. 고선량 방사선조사는 배양 46시간째 $^{137}Cs$ 조사기를 사용하여 2 Gy의 감마선을 조사하였다. 불안정 염색체의 발생빈도를 Ydr값으로 표현하였고, 방사선 적응반응 지수(k)는 저선량 전처치후 Ydr값을 전처치 전 Ydr값으로 나누어 k값이 1 미만일 때 방사선 적응반음이 유도되는 것으로 간주하였다. 대상환자 62명 중 61명에서 방사선 적응반응이 유도되었고 $^{99m}Tc-DTPA,\;^{99m}Tc-MDP$ 및 Tc-99m-TF 환자군에서 k값의 변동계수 (CV)는 각각 35%, 34%, 21%였다. k값은 성별, 나이 및 병명과 상관관계가 없었다. 핵의학검사를 시행한 환자들에서 방사성 의약품에 의해 유도된 방사선 적응반응은 다양한 개인차가 있었으며, 성별, 나이 또는 병명과 관계없는 다른 원인에 의한 것으로 판단되었다.

• 대한핵의학회지
• /
• 제16권1호
• /
• pp.31-39
• /
• 1982

The purpose of the present study is to evaluate the clinical and diagnostic significance of incidental findings of renal and urinary tract abnormalities, and extraosseous uptake of bone scans. The authors analyzed bone scans using $^{99m}Tc-MDP$(methylene diphosphonate) in 1238 cases of bone disease from April, 1979 to March, 1981. The results obtained were as follows. 1. Total extraosseous abnormalities were 112 cases (9%), which include 64 cases (5%) of renal and urinary tract abnormalities and 48 case(4%) of other extraosseous uptakes. 2. Renal and urinary tract abnormalities were 32 cases(50%) of obstruction, 14 cases(22%) of nonvisualization, 6 cases of space occupying lesion in kidney, 8 cases of kidney displacement and 4 cases of urinary bladder deformities. 3. Other extraosseous uptakes were 16 cases (33%) of body fluid collection, 15 cases of tumor uptake, 9 cases of free pertechnetate uptake and 8 others.

• 대한핵의학회지
• /
• 제26권1호
• /
• pp.101-105
• /
• 1992

The leukemias represent diffuse lesions of the bone marrow and significant bony abnormalities are associated with the more aggressive varieties of leukemias and with the younger age groups. On plain film, several roentgenographic findings are observed such as diffuse osteopenia, radiolucent metaphyseal bands, osteolytic lesions and periostitis. We evaluated bone scintigraphic findings using $^{99m}Tc-methylene$ diphosphonate $(^{99m}Tc-MDP)$ in ten patients with proven leukemia. The scan is abnormal in 90%. We classified abnormal scintigraphic findings to 3 types and these are increased diffuse juxta-articular uptake, focal increase of uptake and combined type. The common sites of focal uptake were femur, humerus, tibia, spine, ribs, calvarium, scapula and mandible. We concluded that $(^{99m}Tc-MDP)$ bone scintigraphy is sensitive imaging modality in leukemic patients with bone pain.

• 대한핵의학회지
• /
• 제27권2호
• /
• pp.309-314
• /
• 1993

저자등은 33세 남자 환자에서 검사실 소견과 복부 전산화 단층촬영, 간 신티그라피 및 골주사, 복부 초음파 및 수술소견을 통해 알콜성 및 C형 간염에 의한 간경화를 동반한 환자가 교통사고로 복부 외상에 의한 간하부열상을 받아 복강내출혈로 입원한 환자에서 일시적으로 골주사소견에서 비장에 섭취를 보이는 것이 복부 비장의 잠재적 외상으로 인한 것으로 사료되며, 비장 비대 외에는 특이소견이 보이지 않으며 기전이 명확하지 않은 골주사상 비장섭취를 보인 1예를 경험하였기에 문헌 고찰과 함께 보고하는 바이다.

• 대한핵의학회지
• /
• 제34권3호
• /
• pp.252-259
• /
• 2000

목적: 핵의학과에서 흔하게 이용되는 Tc-99m MDP 또는 Tc-99m DTPA를 주사한 후 방사선 적응반응이 일어나는지를 확인하고, 어느 경우에 방사선 적응반응이 더 현저하게 유도되는지 알아보기 위하여 이 연구를 시행하였다. 대상 및 방법: Tc-99m MDP 또는 Tc-99m DTPA 신티그라피를 시행한 45명의 환자(남자 25명, 여자 20명, 평균 연령 $44{\pm}18$세)를 대상으로 Tc-99m MDP 뜨는 Tc-99m DTPA 주사 전과 주사 후 4시간에 각각 5 ml씩 채혈하여 배양하고 배양 46시간 후에 Cs-137조사기 (central dose rate=654 Gy/h, Gammacell 3000 Elan, Nordion, Canada)를 이용하여 2 Gy의 감마선을 조사하였다. 대조군 20명(남자 12명, 여자 8명, 평균연령 $43{\pm}7$세)의 혈액을 채혈하여 Tc-99m MDP 또는 Tc-99m DTPA 주사 전에 채혈한 군과 같은 방법으로 조사하고 배양하였다. Colcemid 처리 2시간 후에 수확하여 불안정 염색체인 반지형과 이중 중심체형 염색체의 수자를 계수 하여 불안정 염색체 출현빈도(Ydr)를 구하여 비교하였다. 고선량의 방사선 단독조사에 의한 Ydr값과 방사성의약품 투여 후 고선량의 방사선 조사에 의해 유도된 Ydr값의 차이값을 적응반응지수로 정의하고, Tc-99m MDP 신티그라피와 Tc-99m DTPA 신티그라피의 적응반응지수를 비교하였다. 결과. 2 Gy 단독조사에 의한 Ydr값에 비해 Tc-99m MDP 또는 Tc-99m DTPA 주사한 후에 2 Gy 조사한 군에서 Ydr값이 유의하게 감소하였다($0.45{\pm}0.20\;vs.\;0.24{\pm}0.10$, p=0.001). Tc-99m MDP 또는 Tc-99m DTPA에 의해 유도된 적응반응은 단백합성억제제인 cycloheximide에 의해 억제되었다($0.24{\pm}0.10\;vs.\;0.43{\pm}0.16$, p=0.001). Tc-99m MDP 신티그라피에 의한 적응반응 지수는 Tc-99m DTPA 신티그라피에 의한 적응반응지수에 비해 유의하게 높았다($0.10{\pm}0.06\;vs.\;0.24{\pm}0.05$, p=0.0001). 결론: Tc-99m MDP 신티그라피 또는 Tc-99m DTPA 신티그라피에 의한 저선량의 방사선 조사에 의하여 말초혈액 림프구에서 방사선 적응반응이 유도되었고, 적응반응의 정도는 Tc-99m MDP 골 신티그라피를 시행하는 환자에서 더욱 현저함을 알 수 있었다.

• 대한핵의학회지
• /
• 제24권2호
• /
• pp.222-228
• /
• 1990

The development of histomorphometric and histodynamic investigations has permitted the description of a specific and complex osteopathy in hyperthyroidism. The increased bone turnover rate in hyperthyroid patients may be accompanied by a considerable bone loss. These features are associated with both inclosed osteoclastic bone resorption and increased osteoblastric bone formation, with an accelerated calcification rate. Conventional biochemical markers of bone metabolism, i.e. serum calcium and alkaline phosphatase and urinary hydroxyproline and calcium are normal in most patients with hyperthyroidism. However, the correlation between serum BGP and serum concentration of thyroid hormon suggests that serum BGP may be a sensitive marker of increased bone formation due to the hypersecretion of thyroid hormones. Any increase in bone turnover, whether focal or diffuse, will result in an increase in $^{99m}Tc-methylenediphosphonate$ uptake (MDP). The measurement of this uptake in hyperthyroid patients by bone provides a sensitive and objective means of quantifying skeletal metabolism. Using a standard shadow-shield whole-body monitor and radioimmunoassay kit, we have measured whole-body retention of $^{99m}Tc-MDP$ up to 24hr and concentration of serum Osteocalcin in 20 patients with hyperthyroidism and in 42 normals. The results were as follows; 1) The average of serum Osteocalcin level in 42 patients with normals was $9.90{\pm}4.87(ng/ml)$ and in 20 patients with hyperthyroidism was $19.54{\pm}5.7(ng/ml)$. Both the averages of serum Osteocalcin and 24hr $^{99m}Tc-MDP$ uptakes in hyperthyroid patients were higher than those in normals. 2) $^{99m}Tc-MDP$ uptakes in skeletal system increased in proportion to normal ageing after 40 yrs old in 42 patients with normals. The average of $^{99m}Tc-MDP$ uptakes in hyperthyroid patients were higher than those in normals without related ageing. 3) A significant relationships between the $^{99m}Tc-MDP$ uptakes and serum Osteocalcin level were peformed (r=0.55, $y=17.58+6.7\times$). From the above results we concluded that the measurement of serum Osteocalcin and 24hr $^{99m}Tc-MDP$ uptakes can be used for evaluation of bone turnover as a specific marker in hyperthyroid patients.